Natural Lactone‐Based Quorum Sensing Inhibitors Attenuate Virulence in Pseudomonas aeruginosa Authors: Shivani Chaturvedi, Ashutosh Sharma, Tanisha Singh, Bibhuti Bhusan Das, Tanmay Dutta, Sunil Kumar Khare Published: 2026 ABSTRACT ABSTRACTNatural lactones represent a promising anti‐virulence strategy against Pseudomonas aeruginosa by targeting quorum‐sensing (QS) pathways. In this work, we investigate γ‐caprolactone (Capro), γ‐octalactone (Octa), γ‐decalactone (GDL), δ‐decalactone (DDL), and a laboratory‐generated lactone mixture (Lx) as modulators of QS‐regulated virulence. Treatment with γ‐decalactone and engineered lactone formulations significantly downregulated rhlR expression (∼twofold) and suppressed pyocyanin and rhamnolipid production. At 48 h, lactone exposure reduced extracellular virulence factors by up to 74.81% (pyocyanin) and 49.08% (rhamnolipids), indicating effective disruption of quorum sensing signaling. Collectively, these findings demonstrate that biotransformation‐derived lactones attenuate virulence programs in P. aeruginosa, highlighting their potential as quorum sensing inhibitors for managing biofilm‐associated infections.Keywords: antibiotic resistance, Pseudomonas aeruginosa, quorum sensing inhibition, γ‐ decalactone, δ‐decalactone Introduction Multidrug‐resistant organisms have emerged more quickly as a result of the overuse and continuous use of antibiotics to treat bacterial illnesses. Among these, Pseudomonas aeruginosa is a major opportunistic nosocomial pathogen posing a significant threat to human health. Patients suffering from lung infections, burns, cystic fibrosis, immunocompromised conditions, and advanced age are particularly susceptible to infections caused by multidrug‐resistant P. aeruginosa [1]. QS‐regulated phenotypes synchronize the production of virulence factors, which aids in pathogenesis [2]. Genes related to antibiotic resistance, pathogenicity, host interactions, fermentation, exoenzyme production, biofilm formation, and other processes are regulated by various QS systems [2, 3]. Furthermore, QS circuits differ between Gram‐positive and Gram‐negative bacteria and rely on distinct autoinducers. QS interrelationships are important drivers of infection severity, microbial community composition, and host immunometabolic alterations through chromatin modifications. The primary signals include AI‐2, which facilitates interspecies communication, and acyl‐homoserine lactones (AHLs/AI‐1) in Gram‐negative bacteria and autoinducing peptides (AIPs) in Gram‐positive bacteria [4]. AHLs, which are made up of a homoserine‐lactone ring connected to a variable acyl chain, are the main mediators of QS in Gram‐negative bacteria. Enzymes such as luxI, luxM, and htdS synthesize them from S‐adenosyl methionine (SAM) and ACP, and their structural diversity dictates signaling specificity and function. By inhibiting autoinducer production or release, encouraging its breakdown or sequestration, or impeding receptor identification, QS can be blocked at several stages [5]. Because they reduce virulence without compromising bacterial viability, QS inhibitors have drawn interest as antivirulence methods. They also assist in maintaining the native microbiota and lessen the selective pressure associated with traditional antimicrobials [6]. The formation of a biofilm‐associated extracellular polymeric matrix acts as a physical and biochemical barrier that restricts antibiotic diffusion, thereby contributing to antimicrobial resistance. This poses a significant obstacle to the creation of novel therapeutic approaches that focus on virulence rather than bacterial survival. [7] Within biofilm‐mediated virulence, quorum sensing (QS) plays a critical regulatory role in controlling extracellular factors such as rhamnolipids and pyocyanin [8]. The QS network in P. aeruginosa primarily involves the las and rhl systems, comprising luxI‐type synthases (lasI and rhlI) that produce acyl homoserine lactone (AHL) signaling molecules. Upon reaching threshold concentrations, AHLs bind to luxR‐type receptors (lasR and rhlR), forming transcriptional activation complexes that regulate the expression of multiple genes associated with virulence and biofilm development [9]. Using structurally comparable natural lactone compounds to target QS pathways has become a promising antivirulence technique that aims to reduce pathogenicity without applying severe selective pressure for resistance. Such lactones are proposed to interfere with AHL signaling by competing with native QS molecules for binding to their cognate regulatory proteins [10]. A wide range of natural products have previously demonstrated anti‐QS and antibiofilm potential, highlighting the feasibility of this approach [11]. Computational and structure‐based approaches have further supported the identification of QS inhibitors. For example, an in silico bioinformatic study by Kim et al. [12] demonstrated that gingerol, a plant‐derived compound, interacts with the lasR regulator, underscoring the utility of molecular docking in discovering potential QS‐modulating molecules. Similarly, structure‐based virtual screening studies by Chang et al. [13] revealed interactions between trans‐cinnamaldehyde and the substrate‐binding site of lasI. Despite these advances, the potential of lactones to suppress QS activity in P. aeruginosa remains insufficiently explored and is often limited to preliminary morphological or imaging‐based observations. Therefore, in the present study, we investigate the anti‐virulence potential of natural and biotransformation‐derived lactones using an integrated approach that combines reverse transcription quantitative PCR (RT‐qPCR)‐based gene expression analysis and phenotypic profiling of QS‐regulated virulence factors such as rhamnolipids and pyocyanin. Materials and Methods Bacterial Culture, Media, and STRAINS Malt extract, glucose, peptone, yeast extract, potato dextrose agar, and potato dextrose broth were purchased from HiMedia Laboratories (Mumbai, India) and used for culture maintenance and production media preparation. Tryptic soy broth (TSB) for cultivation of P. aeruginosa PAO1 was also obtained from HiMedia Laboratories (Mumbai, India). γ‐Caprolactone (Capro), γ‐decalactone (GDL), δ‐decalactone (DDL), γ‐octalactone (Octa), ethyl acetate, hexane, dichloromethane, crystal violet, glacial acetic acid, and ricinoleic acid were procured from Sigma–Aldrich (India) and SRL Laboratories (India). Castor oil (83% purity), NaOH, HCl, and NaCl were purchased from Merck (India). All other chemicals used were of analytical grade. Selected microbial strains [14] were preserved at −80°C in 40% glycerol stocks. Cultures from MGYPA plates were inoculated into 50 mL MGYP medium and grown to the late logarithmic phase. The cell pellets were subsequently transferred into peptone‐based production medium containing ricinoleic acid (1%) as the carbon source. Fermentation was carried out in shake flasks under controlled conditions for 216 h. Culture samples were collected at defined intervals, and GDL and DDL production was monitored following the previously reported protocol [15]. For biotransformation, ricinoleic acid (1%), derived from castor oil, was added to 2% peptone medium and incubated in an orbital shaker for 216 h. The fermentation broth was extracted three times with ethyl acetate, and the organic phases were pooled and concentrated using a rotary evaporator at 45°C under 180 mbar pressure. GC‐MS was used to analyze the Lx samples; the key lactone concentrations in the samples were: γ‐decalactone was measured at 0.2634 ng/mL, γ‐methyldecalactone at 0.0656 ng/mL, and Octa at 0.0066 ng/mL. [14]. Biofilm Inhibition Studies The anti‐biofilm efficacy of lactones was assessed using P. aeruginosa PAO1. A single colony from a tryptic soy broth (TSB) agar plate was inoculated into 10 mL of TSB and incubated overnight (∼16 h) at 37°C with shaking at 150 rpm. The culture was subsequently diluted 1:100 in fresh TSB, and 100 µL of the diluted suspension was dispensed into sterile 96‐well microtiter plates containing lactones diluted in autoclaved MilliQ water at final concentrations ranging from 100 to 600 µg mL− 1. The plates were incubated under static conditions at 37°C for either 24 or 48 h. Following incubation, planktonic cells were removed, and the wells were washed twice with 1× phosphate‐buffered saline (PBS) to remove nonadherent bacteria. The plates were air‐dried, stained with 0.1% (v/v) crystal violet and kept for 15 min in the dark, and then rinsed to remove the excess dye. The bound stain was solubilized with 33% glacial acetic acid, and biofilm biomass was quantified by measuring absorbance at 590 nm using a microplate reader (Multiskan GO, Thermo Fisher Scientific). Biofilm Eradication Studies For biofilm eradication, mature biofilms were initially established by incubating the inoculated 96‐well plates under static conditions at 37°C for either 24 or 48 h. Lactones, at concentrations of 100–600 µg mL− 1, were then introduced to the preformed biofilms and incubated for an additional 24 h under static conditions. The wells were subsequently washed with PBS, stained with crystal violet, and processed as previously described to quantify residual biofilm biomass (A590). Structural Characterization of Biofilm Under Lactone Treatment The structural morphology of biofilms formed under control and lactone‐treated conditions was investigated using field emission scanning electron microscopy (FE‐SEM; FEI Quanta 200F, Netherlands) operated at an accelerating voltage of 200 kV. Biofilm samples were gently washed to remove nonadherent cells, followed by fixation and dehydration through a graded ethanol series prior to imaging. The surface architecture, cellular aggregation, and extracellular matrix distribution were comparatively analyzed to evaluate structural alterations induced by lactone‐mediated quorum sensing inhibition. RNA Extraction and Quantitative Real‐Time PCR Wild‐type and mutant P. aeruginosa strains were grown overnight in LB medium at 37°C with shaking (200 rpm). Cultures were diluted 1:100 in fresh LB broth and incubated under the same conditions. When the cultures reached the desired optical density (OD600), cells were divided into four groups: Control, DDL‐treated, GDL‐treated, and Lx‐treated. Following treatment, samples were collected at defined time points for RNA analysis. Total RNA was extracted using the RNeasy kit (Qiagen) according to the manufacturer's protocol. Residual genomic DNA was eliminated by DNase I treatment (Fermentas, USA), and RNA concentration and purity were determined spectrophotometrically (Jasco V‐730). For cDNA synthesis, 1 µg of purified RNA was reverse transcribed using the iScript cDNA synthesis kit (Bio‐Rad) with random hexamer primers. The resulting cDNA was diluted 100‐fold with nuclease‐free water, and 1 µL of diluted cDNA was used as the template for quantitative PCR. Amplification was performed using SYBR Green Master Mix (Bio‐Rad) on a CFX96 Touch Real‐Time PCR Detection System (Bio‐Rad). Each qPCR reaction (20 µL) contained approximately 20 ng of cDNA, 1 µM of each primer specific to the target genes (lecA, lecB, phzM, rhlR, and lasR; sequences listed in Table S1), 10 µl of SYBR Green Master Mix, and nuclease‐free water. The 16S rRNA gene served as the internal control for normalization. Relative transcriptional changes were calculated using the 2−ΔΔCt method. All experiments were performed in biological triplicate. Pyocyanin Quantification Assay With minor modifications, the Alayande et al. technique was used to measure P. aeruginosa pyocyanin production [16]. The bacteria were incubated for 24 and 48 h [17] at 37°C in 10 mL of Nutrient broth medium, with lactones. These time points align with the peak pyocyanin production window (16–24 h) reported for PAO1 [18] and are consistent with established QS inhibition protocols using the same strain [19, 20, 21]. To separate the supernatants from the pellet, the cultivated cells were centrifuged at 1500 × g for 10 min after each incubation period. Three milliliters of chloroform was then added to five milliliters of the supernatant, and the mixture was stirred with a vortex mixer. After adding 1 mL of 0.2 M HCl to the chloroform layer, the mixture was centrifuged for 10 min at 1500×g. A Biobase BK‐D590 Double Beam Scanning UV/Vis spectrophotometer was used to evaluate the optical density of the HCl layer at 520 nm. As a control, 0.2 M HCl was utilized (Blank). The following formula was used to get the pyocyanin concentration: Rhamnolipids Estimation Pseudomonas aeruginosa PAO1 cultures were incubated with lactone treatments for 24 and 48 h, and rhamnolipid production was quantified using the colorimetric orcinol–sulfuric acid assay as previously described [22]. Briefly, culture supernatant (1 volume) was mixed with freshly prepared 0.19% orcinol solution in 53% sulfuric acid (9 volumes). The reaction mixture was incubated at 80°C for 30 min, followed by cooling at room temperature for 15 min. Absorbance was measured at 421 nm to estimate rhamnolipid concentration. Statistical Analysis The study presents the average results of each experiment, which were conducted in triplicate. OriginPro 2020b was utilized to evaluate the acquired data and create graphs. Where appropriate, two‐way ANOVA and Tukey's test statistical analysis were used. * indicates p < 0.05 (n = 3). Results Biofilm Inhibition To determine the biofilm‐inhibitory concentration range, a broad spectrum of lactone (Figure 1) concentrations was initially screened to identify doses that suppressed biofilm formation [23]. Therefore, six concentrations were standardized for the analysis (100, 200, 300, 400, 500 and 600 µg/mL) for both 24 and 48 h incubation periods. Structures of lactones used in this study. Among the tested compounds, GDL and DDL demonstrated significant inhibition of biofilm formation at both the lowest (100 µg/mL) and highest (600 µg/mL) concentrations across the two incubation periods. In contrast, Capro, Octa, and the laboratory‐produced lactone mixture (Lx) showed a decreasing trend in biofilm formation (Figure 2). Biofilm Inhibition in terms of % biofilm biomass versus concentration of lactones plot (a) 24 h and (b) 48 h of treatment with different lactones. Data are presented as mean ± SD (n = 3 biological replicates). Biofilm Eradication The biofilm eradication potential of different lactones was evaluated using 24 and 48 h pre‐formed P. aeruginosa biofilms in a 96‐well plate format. The Lx exhibited the highest biofilm eradication efficiency at both time points, indicating strong activity against established biofilms (Figure 3). GDL also showed notable eradication capability, whereas Capro, DDL, and Octa demonstrated moderate yet measurable reductions in biofilm biomass. Biofilm eradication in terms of % biofilm biomass versus concentration of lactones plot (a) 24 h and (b) 48 h of treatment with different lactones. Data are presented as mean ± SD (n = 3 biological replicates). Additionally, biofilm inhibition and eradication in terms of % biofilm inhibition and eradication have been depicted in Figures S1 and S2, respectively, Field‐Emission Scanning Electron Microscopy (FE‐SEM) of P. eruginosa FE‐SEM images provided visual confirmation of biofilm disruption following lactone treatment (Figure 4). The untreated control Figure 4a displayed intact, densely packed cells with a cell length of 1.57–1.72 µm. Upon treatment with GDL Figure 4b, the membrane surface became uneven, the biofilm matrix appeared visibly damaged, and cell length decreased to 1.12–1.08 µm. Treatment with DDL at 48 h Figure 4c resulted in cell aggregation, clear disintegration of the biofilm, further reduction in cell size to 0.50–0.39 µm, and evident membrane damage. Figure 4d,e show biofilms treated with the Lx at 24 and 48 h, respectively. At 24 h, although the biofilm matrix was visibly disrupted, cell dimensions remained comparable to the untreated control. However, at 48 h, Lx treatment caused pronounced effects on both the biofilm matrix and cell morphology, including ruptured and deformed cell membranes. Cell shrinkage was also notable, with dimensions reduced to 0.72–0.67 µm, comparable to the DDL‐treated 48 h sample. Similar biofilm disruption effects have been reported for naringenin at 24 and 72 h using FE‐SEM [24]. FE‐SEM images of P. aeruginosa biofilms. (a) Untreated control at 24 h, (b) GDL at 24 h, (c) DDL at 48 h, (d) Lx at 24 h, (e) Lx at 48 h. Scale bar: 1 µm. The untreated control at 24 h serves as the reference for all panels, as biofilm morphology under control conditions remained comparable at both time points. Pyocyanin Production in the Presence of Lactones Pyocyanin, a blue‐green, redox‐active phenazine pigment, is a critical virulence factor in P. aeruginosa. It generates reactive oxygen species, disrupts host cell signaling, and damages epithelial tissues, thereby facilitating infection and persistence within the host. Its synthesis is predominantly regulated by the las and rhl systems. The impact of lactones on pyocyanin production was evaluated using a pyocyanin assay. At 24 h, lactones modified pyocyanin production relative to the untreated control (blank). GDL induced an increase in pyocyanin production, while DDL and Octa moderately elevated its production. In contrast, Capro resulted in lower production, and Lx was slightly below the control level. A notable contrast was observed at 48 h. When the culture was incubated with lactones for 48 h, there was a significant reduction in pyocyanin production compared to the control. Lx exhibited the strongest suppression of pyocyanin production (∼5 µg/mL), representing an almost fourfold decrease compared to 24 h, followed by DDL and Capro. These findings suggest that the effects of lactones are time‐dependent and structure‐specific. (Figure 5) The early (24 h) stimulation by GDL and Capro may reflect transient QS activation, whereas the marked decline at 48 h suggests delayed inhibitory effects. The progressive inhibition by Lx aligns with QS antagonism, wherein structural analogs compete with native AHLs for lasR/rhlR binding affinity. Pyocyanin production (µg/mL) of P. aeruginosa strain at 24 and 48 h incubation; Blank, and treatments include Capro, GDL, DDL, Lx, and Octa. Data are presented as mean ± SD (n = 3 biological replicates), and statistical significance was assessed by two‐way ANOVA followed by Tukey's post‐hoc test, and the asterisk (*) denotes p < 0.05 versus the untreated control. Rhamnolipids Production Rhamnolipids are essential glycolipid biosurfactants that facilitate surface motility, biofilm development, and host tissue damage in P. aeruginosa infections. Their synthesis is governed by the rhl quorum‐sensing (QS) system, rendering rhamnolipid production a sensitive indicator of QS activity. All lactone treatments reduced rhamnolipid production compared to the untreated control (blank) at both 24 and 48 h. At 24 h, Capro and DDL exhibited a moderate decrease in rhamnolipid production, whereas Octa and GDL showed a slightly stronger reduction. Lx demonstrated the highest decrease in rhamnolipid production. After 48 h, the inhibitory effects of the lactones persisted. Lx exhibited the most pronounced reduction. Capro and DDL remained moderately inhibitory, while Octa and GDL showed a slight decrease compared to 24 h. These results indicate sustained inhibition of rhamnolipid synthesis over time, with Lx consistently being the strongest inhibitor among lactones. The observed decrease in rhamnolipid levels across all lactone treatments suggests that these compounds interfere with QS‐dependent regulation. Lx exerted the most potent inhibition at both time points, supporting the mechanism of direct antagonism of rhlR or competition with native AHLs. Capro, DDL, Octa, and GDL demonstrated partial QS interference or metabolic stress that hindered rhamnolipid synthesis. Rhamnolipids contribute to biofilm maturation and overall virulence of pathogenic bacteria; therefore, suppression by lactones, particularly Lx, underscores its potential as a lead scaffold for anti‐biofilm strategies targeting infections caused by P. aeruginosa (Figure 6). Rhamnolipid production (µg/mL) of P. aeruginosa strain at 24 and 48 h incubation. Blank and treatments include Capro, GDL, DDL, Lx, and Octa. Data are presented as mean ± SD (n = 3 biological replicates), and statistical significance was assessed by two‐way ANOVA followed by Tukey's post‐hoc test, and the asterisk (*) denotes p < 0.05 versus the untreated control. Expression of QS Genes (lasR, lecA, lecB, rhlR, and phzM) RNA of suitable purity (A260/280 values between 1.9 and 2.1) was obtained from all treatment groups. DNase I digestion removed residual genomic DNA, and reverse transcription yielded reproducible cDNA across independent samples. Quantitative PCR was used to examine the effect of DDL, GDL, and Lx on QS gene expression in P. aeruginosa. Single, well‐defined peaks in the melting curves confirmed that all primer sets amplified specific targets. Clear transcriptional changes were detected in two key regulators. Expression of rhlR decreased by roughly twofold in cultures treated with GDL and Lx compared with the untreated control. In contrast, lasR expression rose nearly threefold under the same conditions. Both trends were statistically significant (p < 0.05). DDL treatment did not produce notable differences Normalized fold‐change values, calculated using the 2−ΔΔCt method with 16S rRNA as the reference, are shown in Figure 7. These findings indicate that GDL and Lx shift the balance between the rhlR and lasR regulatory pathways, with suppression of rhlR and enhancement of lasR expression. Gene expression of P. aeruginosa PAO1. Relative gene expression of (a) lasR, (b) lecA, (c) lecB, (d) rhlR, and (e) phzM genes. Data are presented as mean ± SD (n = 3). δ‐decalactone, DDL; γ‐decalactone, GDL; Laboratory generated mixture of lactones; Lx. Quantitative RT‐qPCR was used to evaluate how DDL, GDL, and Lx treatments affect the transcription of key QS regulators (lasR and rhlR) alongside downstream virulence/effector genes (lecA, lecB, and phzM) in Pseudomonas aeruginosa PAO1 (Figure 7). The two main regulators, lasR and rhlR, displayed clear and statistically significant shifts. Treatment with GDL and Lx resulted in a roughly twofold drop in rhlR expression compared to the untreated control (p < 0.05). Conversely, lasR expression rose significantly (up to ∼threefold) under the same conditions. DDL treatment did not cause any notable changes in either regulator. The downstream target genes showed more modest, non‐significant variations across treatments: lecA expression showed a slight upward inclination following DDL, GDL, and Lx exposure, though these changes remained statistically nonsignificant. lecB expression remained largely comparable to the untreated control in GDL and Lx sets, with only a minor, nonsignificant increase in the DDL‐treated sample. phzM, which encodes a key methyltransferase in pyocyanin biosynthesis, showed a slight downward trend with Lx treatment (∼1.0‐fold of control). This mirrors the drop in pyocyanin production seen phenotypically, even though the transcript‐level shift itself did not meet statistical significance. Overall, these results indicate that while GDL and Lx actively shift the primary regulatory nodes by repressing rhlR, downstream effectors such as lecA, lecB, and phzM show more subtle responses at the transcription level under these conditions. Discussions Biofilm‐associated infections are difficult to eradicate and contribute to resistance against systemic antibiotic therapy [25]. Lactones, naturally occurring cyclic esters, have demonstrated antibiofilm activity against P. aeruginosa, positioning them as a promising alternative. Although lactones have been reported to possess antimicrobial [26] and antivirulence properties [27], their potential as biofilm inhibitors remains relatively underexplored. Lactones have shown their potential against P. aeruginosa for inhibition and eradication of biofilms. In the present study, inhibition was more on 48 h treatment compared with 24 h treatment on biofilms. In 24 and 48 h mature biofilms, the removal or eradication was significantly visible. Similar findings were reported by Ma et al.; they found 50%–70% inhibition of biofilm with the use of chitosan‐stabilized silver and gold nanoparticles in P. aeruginosa [28]. Extracellular polymeric substances (EPS) secreted by P. aeruginosa provide a platform for adhering bacterial cells to embed in the matrix to form biofilm. This biofilm proves to be a shield from antibiotics or the host's immune system [29, 30]. This underscores the need for molecules capable of penetrating the EPS matrix to inhibit or eradicate bacterial growth within. In the present study, lactone treatment reduced the residual biofilm biomass of pre‐formed biofilms at both time points (Figure 3). At 600 µg/mL, residual biomass of 24 h mature biofilms decreased to 50.5% (Capro), 47.2% (GDL), 57.5% (DDL), 49.6% (Octa), and 42.5% (Lx) relative to the untreated control. A similar but more pronounced reduction was observed in 48 h mature biofilms, with residual biomass of 49% (Capro), 46% (GDL), 56% (DDL), 48% (Octa), and 41% (Lx). Lx consistently yielded the lowest residual biomass at both time points. The increased eradication of all the lactones from 24 to 48 h in mature biofilm could be due to the fact that, with increasing time, the compactness of the EPS matrix reduces and some compositional alteration in the structure of the matrix occurs. As the matrix loses its compactness, lactones are easily able to penetrate the matrix of EPS and reach out the bacterial cell. In previous research the chitosan stabilized silver and gold nanoparticles were utilized to inhibit biofilm (50%–70%) produced by P. aeruginosa [28]. Similarly, the use of emodin and kaempferol showed the highest inhibition and eradication of biofilm (more than 50%) [31]. FE‐SEM analysis confirmed the structural impact of lactone molecules on the biofilm matrix of P. aeruginosa, revealing disruption of the compact biofilm architecture. The bacterial cells become crumpled, with wrinkles on the cell membrane along with a reduction in cell size, clearly showing the impact on the biofilm by enhancing membrane permeability and damaging its integrity. These results are supported by Wen et al., research, where EPS gets disrupted by naringenin [32]. Similarly, silver nanoparticles also impacted cell membrane structure [33]. The results of FE‐SEM displayed a clear impact on multiple key steps of biofilm formation. Consistent with biofilm eradication trends, virulence factors such as pyocyanin (74.8% reduction) and rhamnolipids (49% reduction) were more strongly suppressed at 48 h compared to 24 h (0.28% and 20.9%, respectively). Similar reductions in pyocyanin production have been reported using Ag‐carth [34], silver [35], and gold nanoparticles [36]. Because pyocyanin levels are directly linked to virulence intensity and infection severity [37], their reduction suggests decreased pathogenic potential. Lower pyocyanin levels may also reduce extracellular DNA release, potentially destabilize the biofilm matrix and reduce its viscosity and structural integrity [38]. Collectively, these findings support the role of lactones as QS–modulating agents capable of attenuating virulence and disrupting biofilm architecture in P. aeruginosa. Furthermore, our RT‐qPCR data demonstrated a simultaneous downregulation of rhlR alongside an upregulation of lasR upon lactone treatment (Figure 7). Rather than simple direct receptor antagonism alone, this reciprocal response suggests a complex regulatory interplay. These natural lactones likely modulate the hierarchical QS network via upstream global regulatory nodes (such as QscR, GacA/GacS, or VqsR signaling cascades) or indirect feedback circuits, ultimately dampening RhlR‐dependent virulence pathways. Conclusion Development of novel antimicrobials and anti‐biofilm agents that are biobased natural materials can target bacterial biofilms formed by P. aeruginosa, and therefore they are a promising avenue to address the problem of antibiotic resistance. The present research demonstrates that the bio‐transformed product lactone mixture represses the rhlR and thus downregulates the virulence genes of P. aeruginosa, demonstrating its inhibitory qualities against major virulence factors like pyocyanin and rhamnolipids. It is believed that the host immune system will be able to combat any infections that the treatment cannot if virulence can be managed. Author Contributions Shivani Chaturvedi: conceptualization, experimental plan, data curation, methodology, validation, investigation, funding acquisition, and writing – review and editing. Ashutosh Sharma: data curation for molecular studies. Tanisha Singh: data curation for virulence factors and graph formation using software. Bibhuti Bhusan Das: data curation. Tanmay Dutta: validation, investigation, and reviewing the article editing and supervision. Sunil Kumar Khare contributed to methodology, validation, investigation, and review, editing, and supervision. Conflicts of Interest The authors declare no conflicts of interest. Supporting information Supporting File 1: cbdv71734‐sup‐0001‐SuppMat.docx. Acknowledgments The author Dr. S. Chaturvedi is thankful to DST for the Women Scientist Fellowship (DST/WOS‐A/CS‐94/2021). Data Availability Statement The data that support the findings of this study are available in the Supporting Information of this article. References Associated Data Supplementary Materials Supporting File 1: cbdv71734‐sup‐0001‐SuppMat.docx. Data Availability Statement The data that support the findings of this study are available in the Supporting Information of this article.